Novo Nordisk’s CEO says compounded GLP-1 knockoffs sourced from overseas ingredients could endanger patients and undermine FDA oversight as legal battle escalates.
The FDA announced Friday that it intends to restrict the active pharmaceutical ingredients of glucagon-like peptide-1 (GLP-1) ...
The U.S. Food and Drug Administration (FDA) plans to take steps to limit the use of GLP-1 in non-FDA-approved compounded ...
Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...
OpenLoop, a company providing operational and tech services to telehealth companies, and compounding pharmacy Triad Rx are being sued in a class action for selling oral tirzepatide. | The complaint ...
Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.
Compounding pharmacies are facilities that are able to make customized medications. This could be to alter a drug's dosage or composition for medical purposes. Many patients have benefitted from drug ...
Sen. Tom Cotton, R-Ark., warned that up to 1.5 million Americans may be using weight loss medications with potentially dangerous Chinese ingredients.
Compounding drugs prior to receipt of a valid prescription. Compounding drugs removed from the market for safety reasons. Compounding drugs that are essentially copies of commercially available ...
The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results